GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Femtobiomed Inc (XKRX:327610) » Definitions » Preferred Dividends

Femtobiomed (XKRX:327610) Preferred Dividends : ₩0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Femtobiomed Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Femtobiomed's preferred dividends for the six months ended in Dec. 2024 was ₩0.0 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Dec. 2024 was ₩0.0 Mil.


Femtobiomed Preferred Dividends Historical Data

The historical data trend for Femtobiomed's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Femtobiomed Preferred Dividends Chart

Femtobiomed Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Preferred Dividends
Get a 7-Day Free Trial - - - - -

Femtobiomed Semi-Annual Data
Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Preferred Dividends Get a 7-Day Free Trial - - - - -

Femtobiomed Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.


Femtobiomed  (XKRX:327610) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Preferred Dividends for the trailing twelve months (TTM) ended in Dec. 2024 was ₩0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Femtobiomed Business Description

Traded in Other Exchanges
N/A
Address
17 Pangyo-ro 228 (ibaegisippal) beo, Sampyeong-dong, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13487
Femtobiomed Inc is a South Korea based company engaged in developing a cargo-free intracellular delivery platform called Cell Shot Platform. It is focused on using this technology to work on cell-based therapeutic pipelines.

Femtobiomed Headlines

No Headlines